7501 - 7550 of 7916 Results
Title
Year
-
OPENTitle: Network correlates of the cognitive response to levodopa in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 9Start Page: 858End Page: 865Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31822c6224Best OA location URL: https://europepmc.org/articles/pmc3162641?pdf=renderCitation Count: 61
- Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging2011OPENTitle: Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imagingJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 1Start Page: 90End Page: 97Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23917Best OA location URL: https://europepmc.org/articles/pmc4472452?pdf=renderCitation Count: 171
-
OPENTitle: Neurologist care in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 9Start Page: 851End Page: 857Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31822c9123Best OA location URL: https://europepmc.org/articles/pmc3162639?pdf=renderCitation Count: 247
-
OPENTitle: Induction of pluripotent stem cells from autopsy donor-derived somatic cellsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 502Issue #: 3Start Page: 219End Page: 224Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2011.07.048Best OA location URL: https://europepmc.org/articles/pmc3195418?pdf=renderCitation Count: 25
- Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor2011OPENTitle: Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factorJournal Name: NeurosciencePublisher: Elsevier BVVol: 194Issue #:Start Page: 220End Page: 226Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2011.07.072Best OA location URL: https://europepmc.org/articles/pmc3408714?pdf=renderCitation Count: 34
-
RESTRICTEDTitle: Cdk5: Mediator of neuronal development, death and the response to DNA damageJournal Name: Mechanisms of Ageing and DevelopmentPublisher: Elsevier BVVol: 132Issue #: 8-9Start Page: 389End Page: 394Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.mad.2011.04.011Best OA location URL: https://europepmc.org/articles/pmc3179526?pdf=renderCitation Count: 25
-
RESTRICTEDTitle: The cholinergic system and Parkinson diseaseJournal Name: Behavioural Brain ResearchPublisher: Elsevier BVVol: 221Issue #: 2Start Page: 564End Page: 573Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbr.2009.12.048Best OA location URL: https://europepmc.org/articles/pmc2888997?pdf=renderCitation Count: 447
- Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding Activities2011OPENTitle: Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding ActivitiesJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 412Issue #: 1Start Page: 94End Page: 110Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2011.07.033Best OA location URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158845/pdf/nihms313870.pdfCitation Count: 120
-
OPENTitle: CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1408Issue #:Start Page: 88End Page: 97Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2011.06.057Best OA location URL: https://europepmc.org/articles/pmc4120020?pdf=renderCitation Count: 67
- Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets2011OPENTitle: Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and plateletsJournal Name: Biochimica et Biophysica Acta (BBA) - Molecular Basis of DiseasePublisher: Elsevier BVVol: 1812Issue #: 11Start Page: 1508End Page: 1514Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.bbadis.2011.07.004Best OA location URL: https://doi.org/10.1016/j.bbadis.2011.07.004Citation Count: 58
- Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesia2011OPENTitle: Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesiaJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 134Issue #: 8Start Page: 2339End Page: 2357Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awr165Best OA location URL: https://academic.oup.com/brain/article-pdf/134/8/2339/13735225/awr165.pdfCitation Count: 127
- Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics2011RESTRICTEDTitle: Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeuticsJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 119Issue #: 1Start Page: 39End Page: 52Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s00702-011-0682-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-011-0682-x.pdfCitation Count: 68
-
OPENTitle: Olfactory dysfunction in LRRK2 G2019S mutation carriersJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 4Start Page: 319End Page: 324Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318227041cBest OA location URL: https://europepmc.org/articles/pmc3140803?pdf=renderCitation Count: 58
-
OPENTitle: Obesity, diabetes, and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 12Start Page: 2253End Page: 2259Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23855Best OA location URL: https://europepmc.org/articles/pmc3627531?pdf=renderCitation Count: 148
-
OPENTitle: Effects of parkinsonism on health status in welding exposed workersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 17Issue #: 9Start Page: 672End Page: 676Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.05.021Best OA location URL: https://europepmc.org/articles/pmc3200492?pdf=renderCitation Count: 21
- Role of Cerebrospinal Fluid and Plasma Biomarkers in the Diagnosis of Neurodegenerative Disorders and Mild Cognitive Impairment2011RESTRICTEDTitle: Role of Cerebrospinal Fluid and Plasma Biomarkers in the Diagnosis of Neurodegenerative Disorders and Mild Cognitive ImpairmentJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 5Start Page: 455End Page: 463Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-011-0212-0Best OA location URL: https://europepmc.org/articles/pmc3213691?pdf=renderCitation Count: 10
-
OPENTitle: VPS35 Mutations in Parkinson DiseaseJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 89Issue #: 1Start Page: 162End Page: 167Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.ajhg.2011.06.001Best OA location URL: http://www.cell.com/article/S0002929711002424/pdfCitation Count: 802
-
OPENTitle: Disease‐related and genetic correlates of psychotic symptoms in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 12Start Page: 2190End Page: 2195Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23806Best OA location URL: https://europepmc.org/articles/pmc4216677?pdf=renderCitation Count: 68
- Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: Four cases2011RESTRICTEDTitle: Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: Four casesJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 310Issue #: 1-2Start Page: 100End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2011.06.003Citation Count: 32
- Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium2011OPENTitle: Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortiumJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 307Issue #: 1-2Start Page: 22End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2011.05.031Best OA location URL: https://europepmc.org/articles/pmc3155471?pdf=renderCitation Count: 48
- Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's Disease2011OPENTitle: Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's DiseaseJournal Name: PLoS GeneticsPublisher: Public Library of Science (PLoS)Vol: 7Issue #: 6Start Page: e1002141End Page: e1002141Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pgen.1002141Best OA location URL: https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1002141&type=printableCitation Count: 507
- A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patients2011RESTRICTEDTitle: A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patientsJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 310Issue #: 1-2Start Page: 248End Page: 250Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2011.05.021Citation Count: 37
-
OPENTitle: Lrrk2 p.Q1111H substitution and Parkinson’s disease in Latin AmericaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 17Issue #: 8Start Page: 629End Page: 631Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.05.003Best OA location URL: https://europepmc.org/articles/pmc3167927?pdf=renderCitation Count: 16
-
OPENTitle: Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 134Issue #: 8Start Page: 2358End Page: 2365Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awr139Best OA location URL: https://academic.oup.com/brain/article-pdf/134/8/2358/1015592/awr139.pdfCitation Count: 107
- Incidental Lewy body disease: Electrophysiological findings suggesting pre-clinical Lewy body disorders2011OPENTitle: Incidental Lewy body disease: Electrophysiological findings suggesting pre-clinical Lewy body disordersJournal Name: Clinical NeurophysiologyPublisher: Elsevier BVVol: 122Issue #: 12Start Page: 2426End Page: 2432Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.clinph.2011.03.033Best OA location URL: https://europepmc.org/articles/pmc3164932?pdf=renderCitation Count: 12
-
OPENTitle: Head injury, alpha‐synuclein Rep1, and Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 71Issue #: 1Start Page: 40End Page: 48Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.22499Best OA location URL: https://europepmc.org/articles/pmc3270814?pdf=renderCitation Count: 92
-
OPENTitle: Quantitative EEG as a predictive biomarker for Parkinson disease dementiaJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 2Start Page: 118End Page: 124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318224af8dBest OA location URL: https://europepmc.org/articles/pmc3140072?pdf=renderCitation Count: 194
-
OPENTitle: Diagnosis and Referral Delay in Women With Parkinson's DiseaseJournal Name: Gender MedicinePublisher: Elsevier BVVol: 8Issue #: 3Start Page: 209End Page: 217Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.genm.2011.05.002Best OA location URL: https://europepmc.org/articles/pmc3966522?pdf=renderCitation Count: 57
-
RESTRICTEDTitle: Inclusion and exclusion criteria for DBS in dystoniaJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23482Best OA location URL: https://europepmc.org/articles/pmc8478120?pdf=renderCitation Count: 88
- Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease2011OPENTitle: Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's DiseaseJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 1048End Page: 1057Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2011.11Best OA location URL: http://www.cell.com/article/S1525001616319098/pdfCitation Count: 128
- Neuropathological findings of PSP in the elderly without clinical PSP: Possible incidental PSP?2011OPENTitle: Neuropathological findings of PSP in the elderly without clinical PSP: Possible incidental PSP?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 17Issue #: 5Start Page: 365End Page: 371Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.02.017Best OA location URL: https://europepmc.org/articles/pmc3109165?pdf=renderCitation Count: 48
-
OPENTitle: Transcription Factor-Induced Lineage Selection of Stem-Cell-Derived Neural Progenitor CellsJournal Name: Cell Stem CellPublisher: Elsevier BVVol: 8Issue #: 6Start Page: 663End Page: 675Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.stem.2011.04.001Best OA location URL: http://www.cell.com/article/S1934590911001664/pdfCitation Count: 69
-
OPENTitle: Stress and the risk of multiple sclerosisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 22Start Page: 1866End Page: 1871Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31821d74c5Best OA location URL: https://europepmc.org/articles/pmc3115807?pdf=renderCitation Count: 61
- Loss of Thr286 phosphorylation disrupts synaptic CaMKIIα targeting, NMDAR activity and behavior in pre-adolescent mice2011OPENTitle: Loss of Thr286 phosphorylation disrupts synaptic CaMKIIα targeting, NMDAR activity and behavior in pre-adolescent miceJournal Name: Molecular and Cellular NeurosciencePublisher: Elsevier BVVol: 47Issue #: 4Start Page: 286End Page: 292Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.mcn.2011.05.006Best OA location URL: https://europepmc.org/articles/pmc3149813?pdf=renderCitation Count: 47
-
OPENTitle: Neurochemical phenotypes of myenteric neurons in the rhesus monkeyJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 519Issue #: 17Start Page: 3387End Page: 3401Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.22679Best OA location URL: https://europepmc.org/articles/pmc4033411?pdf=renderCitation Count: 24
-
OPENTitle: Mood and cognition in leucine‐rich repeat kinase 2 G2019S Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 10Start Page: 1875End Page: 1880Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23746Best OA location URL: https://europepmc.org/articles/pmc3972755?pdf=renderCitation Count: 40
- Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease2011OPENTitle: Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 11Start Page: 2051End Page: 2057Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23792Best OA location URL: https://europepmc.org/articles/pmc3168697?pdf=renderCitation Count: 77
-
RESTRICTEDTitle: Serotonergic mediated body mass index changes in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 43Issue #: 3Start Page: 609End Page: 615Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2011.05.009Citation Count: 43
-
OPENTitle: Repeatability of Aerobic Capacity Measurements in Parkinson DiseaseJournal Name: Medicine & Science in Sports & ExercisePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 43Issue #: 12Start Page: 2381End Page: 2387Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1249/mss.0b013e31822432d4Best OA location URL: https://journals.lww.com/acsm-msse/fulltext/2011/12000/repeatability_of_aerobic_capacity_measurements_in.20.aspxCitation Count: 45
-
RESTRICTEDTitle: PD biomarkers—use of α-synuclein reaches new levelsJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 6Start Page: 308End Page: 309Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nrneurol.2011.66Best OA location URL: https://europepmc.org/articles/pmc4043344?pdf=renderCitation Count: 1
-
OPENTitle: A family with parkinsonism, essential tremor, restless legs syndrome, and depressionJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 19Start Page: 1623End Page: 1630Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318219fb42Best OA location URL: https://europepmc.org/articles/pmc3100088?pdf=renderCitation Count: 27
-
OPENTitle: Parkinson's disease, cortical dysfunction, and alpha‐synucleinJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 8Start Page: 1436End Page: 1442Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23697Best OA location URL: https://europepmc.org/articles/pmc3154995?pdf=renderCitation Count: 20
-
OPENTitle: Abnormal calcium homeostasis and protein folding stress at the ERJournal Name: Communicative & Integrative BiologyPublisher: Informa UK LimitedVol: 4Issue #: 3Start Page: 258End Page: 261Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.4161/cib.4.3.15019Best OA location URL: https://www.tandfonline.com/doi/pdf/10.4161/cib.4.3.15019?needAccess=true&role=buttonCitation Count: 36
- Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures2011OPENTitle: Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structuresJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 118Issue #: 5Start Page: 795End Page: 808Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-011-0653-2Best OA location URL: https://europepmc.org/articles/pmc3376651?pdf=renderCitation Count: 255
- Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease2011OPENTitle: Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 122Issue #: 1Start Page: 49End Page: 60Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-011-0831-1Best OA location URL: https://europepmc.org/articles/pmc3362487?pdf=renderCitation Count: 84
-
RESTRICTEDTitle: Rationale for Therapeutic Silencing of Alpha-Synuclein in Parkinson’s DiseaseJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 4Issue #: 1Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.11001Best OA location URL: https://doi.org/10.14802/jmd.11001Citation Count: 15
- Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications2011RESTRICTEDTitle: Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applicationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 8Start Page: 1386End Page: 1397Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23737Best OA location URL: https://europepmc.org/articles/pmc3150637?pdf=renderCitation Count: 36
-
RESTRICTEDTitle: Priorities in Parkinson's disease researchJournal Name: Nature Reviews Drug DiscoveryPublisher: Springer Science and Business Media LLCVol: 10Issue #: 5Start Page: 377End Page: 393Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nrd3430Citation Count: 369
-
OPENTitle: Group patient visits for Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 18Start Page: 1542End Page: 1547Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182194badBest OA location URL: https://europepmc.org/articles/pmc3100128?pdf=renderCitation Count: 22
-
RESTRICTEDTitle: Biomarkers for Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 3Issue #: 79Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3002488Citation Count: 40